Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: As of December, 1(st), 2020, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, resulted in more than 1 472 917 deaths worldwide and death toll is still increasing exponentially. Many COVID-19 infected people are asymptomatic or experience moderate symptoms and recover without med...

Descripción completa

Detalles Bibliográficos
Autores principales: Dioh, W., Chabane, M., Tourette, C., Azbekyan, A., Morelot-Panzini, C., Hajjar, L. A., Lins, M., Nair, G. B., Whitehouse, T., Mariani, J., Latil, M., Camelo, S., Lafont, R., Dilda, P. J., Veillet, S., Agus, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797700/
https://www.ncbi.nlm.nih.gov/pubmed/33430924
http://dx.doi.org/10.1186/s13063-020-04998-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797700/
https://www.ncbi.nlm.nih.gov/pubmed/33430924
http://dx.doi.org/10.1186/s13063-020-04998-5

Ejemplares similares